News

AddToAny

Google+ Facebook Twitter Twitter

Blood sample analysis

Nightingale Health will analyse the biomarker profiles of 500,000 blood samples from UK Biobank. 

p8-13-News-Blood-testing--Istock--520292052.jpg

Nightingale’s biomarker profiling technology will be used to analyse UK Biobank blood samples by measuring metabolic biomarkers that recent studies have found are predictive of future risk for heart disease, type 2 diabetes and many other common chronic diseases.

Until recently, technological constraints and prohibitive costs have prevented the analysis of comprehensive metabolic data from large-scale biobank collections.

nightingalehealth.com
 

Image credit | iStock

Related Articles

Avoid "Wild West testing"

The IBMS has circulated a statement to all major media outlets and MPs stating that we must avoid a “Wild West testing” scenario in the UK.

The cancer test of the future?

The efforts of cancer research scientists around the world continue to throw up new possibilities that could give clinicians the edge in the fight against the disease. The latest is a blood test that, it is claimed, may be able to detect more than 50 different types of cancer.

Blood test for Alzheimer's

A point-of-care blood test is being developed to swiftly reveal if a patient with memory issues has Alzheimer’s disease or mild cognitive impairment.

April tech news

Latest tech news for April.

Top